Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer

Clinical trial NCT03273595 · UNKNOWN

Trial details

NCT number: NCT03273595
Sponsor: Xijing Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2016-07-01
Primary completion: 2019-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.